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Abstract
Background: Neurogenic pulmonary edema (NPE) is a non-cardiogenic form of pulmonary edema that can occur
consequent to central neurologic insults including stroke, traumatic brain injury, and seizure. NPE is a public health
concern due to high morbidity and mortality, yet the mechanism(s) are unknown. We hypothesized that NPE,
evoked by cerebral hypoxia in the presence of systemic normoxia, would be accompanied by sympathetic
activation, oxidative stress, and compensatory antioxidant mechanisms.
Methods: Thirteen Walker hounds were assigned to cerebral hypoxia (SaO2 ~ 55 %) with systemic normoxia
(SaO2 ~ 90 %) (CH; n = 6), cerebral and systemic (global) hypoxia (SaO2 ~ 60 %) (GH; n = 4), or cerebral and systemic
normoxia (SaO2 ~ 90 %) (CON; n = 3). Femoral venous (CH and CON) perfusate was delivered via cardiopulmonary
bypass to the brain and GH was induced by FiO2 = 10 % to maintain the SaO2 at ~60 %. Lung wet to lung dry
weight ratios (LWW/LDW) were assessed as an index of pulmonary edema in addition to hemodynamic
measurements. Plasma catecholamines were measured as markers of sympathetic nervous system (SNS) activity.
Total glutathione, protein carbonyls, and malondialdehyde were assessed as indicators of oxidative stress. Brain and
lung compensatory antioxidants were measured with immunoblotting.
Results: Compared to CON, LWW/LDW and pulmonary artery pressure were greater in CH and GH. Expression of
hemeoxygenase-1 in brain was higher in CH compared to GH and CON, despite no group differences in oxidative
damage in any tissue. Catecholamines tended to be higher in CH and GH.
Conclusion: Cerebral hypoxia, with systemic normoxia, is not systematically associated with an increase in oxidative
stress and compensatory antioxidant enzymes in lung, suggesting oxidative stress did not contribute to NPE in
lung. However, increased SNS activity may play a role in the induction of NPE during hypoxia.
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Background
Neurogenic pulmonary edema (NPE) is an acute pulmon-
ary edema that develops after a central neurologic insult,
and is believed to occur independent of a cardiogenic con-
tribution [1]. NPE can occur following stroke, traumatic
brain injury, and seizure, and represents a major public
health concern due to high morbidity (40-50 %) and
mortality (7 %) [2]. Currently, the underlying mecha-
nism(s) of NPE are poorly understood. However, in animal
models increased intracranial pressure (ICP) coupled to
increased sympathetic nervous system (SNS) activation is
strongly linked to development of NPE [3, 4]. In addition
to increased ICP and SNS activation, cerebral hypoxia is a
common feature of many neuropathologies such as stroke,
brain injury, and seizure [5], suggesting that cerebral hyp-
oxia may be an important factor in the pathogenesis of
NPE.
In the past four decades only a handful of studies have
sought to investigate the mechanistic link between
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cerebral hypoxia and the induction of pulmonary edema.
Between 1971–1976, Moss and Stein pioneered a canine
model in which cerebral hypoxia was induced by direct-
ing venous perfusate to the brain in the presence of pul-
monary and systemic normoxia, resulting in pulmonary
edema [6–9]. Although their work showed that cerebral
hypoxia can lead to pulmonary edema, the authors only
speculated on a mechanism, which was thought to be
hydrostatic in origin from increased pulmonary venous
resistance [6–9]. More recently, our group confirmed
and extended the findings of the Moss model to show
cerebral hypoxia-induced pulmonary edema occurred via
a mechanisms other than increased hydrostatic pressure
in the pulmonary vasculature [10]. However, in our pre-
vious experiment, alterations in ICP, cerebral blood flow
(CBF), or reactive oxygen species (ROS), were not
assessed as potential mechanisms of altered lung perme-
ability that lead to pulmonary edema. It is plausible that
cerebral hypoxia contributes to pulmonary edema not
only through a hypoxic pulmonary vasoconstrictive ef-
fect but also by increasing ICP, which subsequently trig-
gers increased SNS activation [4]. In animal models of
NPE there is pronounced activation of the SNS as a ne-
cessary prerequisite for the development of NPE [11].
Increased ICP due to hypoxia could be caused by either
brain tissue swelling or increased CBF to the brain to
counteract brain tissue hypoxia [12, 13].
Cerebral hypoxia also promotes generation of ROS,
leading to increased oxidative damage to lipids, proteins,
and DNA [14]. There is an established link between in-
creased oxidative stress and the pathogenesis of an array
of human diseases [15] including a potential role of oxi-
dants in the pathogenesis of acute lung injury [16–18]. It
is therefore possible that cerebral hypoxia induces exces-
sive circulating brain derived ROS that impair pulmon-
ary endothelial barrier function and contribute to the
development of NPE.
The endogenous cellular antioxidant defense system
consists of approximately 400 proteins [19]. The tran-
scription factor nuclear factor erythroid 2 related factor
2 (Nrf2) is the master regulator of endogenous cellular
antioxidant defenses [20]. Through transcriptional acti-
vation of an antioxidant response element (ARE) bearing
genes involved in antioxidant defenses, such as the phase
II antioxidants superoxide dismutase 1 (SOD1), NAD
(P) H: quinone oxidoreductase 1 (NQO1), and heme ox-
ygenase 1 (HO-1), Nrf2 activates cellular pathways that
protect against oxidative injury [20–22].
Nrf2 can be activated by oxidants produced during
hypoxia [23]. Further, it has been shown that HO-1 in-
creases in the rostral ventrolateral medulla during
chronic hypoxia and is associated with cardiorespiratory
adaptations to hypoxia [24]. Sharma et al. showed that
during hypoxia, SOD1 expression is increased in the
cortex to neutralize the hypoxia-induced ROS generation
[25]. Given the evidence of ROS generation during hyp-
oxia, and based on studies that have suggested a role for
oxidative stress in induction of pulmonary edema, we in-
vestigated whether or not oxidative stress and compen-
satory antioxidants (HO-1, NQO1 and SOD1) play a
role in both cerebral and global hypoxia-induced pul-
monary edema.
Herein, based on our previous work demonstrating
that cerebral hypoxia-induced pulmonary edema was
not due to a hydrostatic origin [10], we hypothesized
that pulmonary edema, evoked by cerebral hypoxia in
the presence of systemic normoxia, is associated with in-
creased ICP, SNS activation, and increased oxidative
stress. In the present study, we designed experiments to
monitor ICP, control CBF, and analyze markers for oxi-
dative stress in both the brain and lung utilizing both
cerebral-hypoxia induced NPE and global hypoxia-
induced pulmonary edema models.
Methods
Experimental design
All surgical procedures and methods were approved by
Colorado State University Animal Care and Use Com-
mittee (protocol numbers: 09-1351A and 11-2663A) and
adhered to the Guide for the Care and Use of Agricul-
tural Animals in Agricultural Research and Teaching.
Thirteen male adult Walker hounds (25 – 30 kg), 4 years
of age, were housed in individual stalls (Veterinary
Teaching Hospital of Colorado State University, Fort
Collins, Colorado, USA) , provided water and food ad
libitum in 5000 feet of altitude, were adapted to these
conditions for at least 1 week before being used in the
experiments, and randomly assigned to one of three
groups: (1) control (CON, n = 3), cerebral normoxia with
systemic normoxia (SaO2 ~ 90 %); (2) cerebral hypoxia
(CH, n = 6), cerebral hypoxia (SaO2 ~ 55 %) with sys-
temic normoxia (SaO2 ~ 90 %); (3) global hypoxia (GH,
n = 4), systemic hypoxia (SaO2 ~ 60 %). All efforts were
made to minimize the suffering and the number of ani-
mals. This work is written according to the ARRIVE
guidelines (http://www.nc3rs.org.uk/ARRIVE/).
Table 1 Arterial oxygen saturation (SaO2) of blood from femoral
and carotid arteries in CON, CH and GH animals after 2 h of
hypoxia
Femoral artery SaO2 Carotid artery SaO2
CON 95.80 ± 3.42 95.60 ± 2.82
CH 94.50 ± 1.73 54.68 ± 6.27*
GH 61.95 ± 2.15** 60.00 ± 3.78*
*p < 0.05 compared to CON femoral artery and CON carotid artery, **p < 0.05
compared to CH femoral artery). Data presented as mean ± SEM
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Instrumentation
Anesthetic and surgical procedures were adapted from
those previously described methods [10] and reflecting a
modification to the original model developed by Moss and
Stein [9]. Following an overnight fast, the dogs were
sedated with fentanyl (10 μg/kg SQ), atropine (0.04 mg/kg
SQ) and midazolam (0.2 mg/kg SQ) 30 min prior to
anesthetic induction. Anesthesia was induced by propofol
(2.5 mg/kg IV) and maintained by fentanyl (0.01 mg/kg
IV). Once a surgical plane of anesthesia was confirmed,
animals in the GH group were intubated and placed on a
volume ventilator (10 breaths/minute) with 100 % oxygen
and isoflurane (1.0-2.0 %) during surgical isolation of the
jugular veins, carotid, and femoral arteries. A catheter was
placed underneath the meninges to estimate intracranial
pressure (ICP). ICP was recorded every 15 min on a
pressure monitor (Marquet 7000, Fridley, MN). Cerebral
perfusion pressure (CPP) (mmHg) was calculated by sub-
tracting the ICP (mmHg) from the mean arterial pressure
(MAP) (mmHg). Cardiac output (CO) was measured by
thermodilution method [26] with 10 mL of iced saline.
Pulmonary arterial pressure (PAP) and capillary wedge
pressure (Pwedge) were assessed using a Swan-Ganz
catheter inserted into the pulmonary artery. A catheter was
placed in a dorsal pedal artery to measure MAP. Stroke
volume (SV) and systemic vascular resistance (SVR) were
calculated from the quotients of CO (L/min) divided
by HR (bpm), and MAP divided by CO respectively.
Pulmonary vascular resistance (PVR) was calculated
by the subtraction of Pwedge from PAP divided by
CO ((PAP-Pwedge)/CO) and is presented as the product
of dyne and time relative to cm5 (dyn*s/cm5). A 2 mm
flow probe (Transonic, Transonic Systems, Inc., Ithaca,
NY) was placed around each carotid artery to measure
blood flow. Data were collected at baseline and then every
30 min during the experiment.
Induction of cerebral or global hypoxia
Dogs assigned to the cerebral hypoxia cohort had their
left femoral vein cannulated with a 14 Fr cannula and
connected to the inlet port of a cardiopulmonary bypass
pump (Roller pump, Cobe, Lakewood, CO, USA). Both
carotid arteries were cannulated with an 8 Fr cannula
and connected to the pump outlet with a “Y” connector.
When venous and arterial isolations were achieved, the
animals were weaned to 21 % O2 and ventilation rate
adjusted to 8 - 10 breaths/minute to maintain normal
systemic partial pressure of CO2 and oxygen saturation
(SaO2 ~ 95 %). To maintain control over cerebral hyp-
oxic blood flow and insure oxygenated arterial blood
was not entering the brain via the vertebral arteries, both
vertebral arteries were isolated at the level of 7th cervical
vertebrae and occluded by tourniquets during the time
course of cerebral hypoxia.
After normal carotid blood flow was achieved from
the cardiopulmonary bypass pump, carotid arteries were
perfused with femoral venous blood desaturated to 60 %
for the CH group or saturated to ~95 % for the CON
group. Carotid arterial blood flow of the CH cohort was
matched to the blood flow of the GH cohort. Carotid
arterial blood flow in the CON group was clamped at
baseline values obtained prior to cannulation of carotid
arteries. All animals underwent 2 hours of hypoxia (or
normoxia in the CON group).
As described above, once a surgical plane of anesthesia
with isoflurane (1.0-2.0 %) was confirmed, animals in the
GH group were intubated and placed on a volume ventila-
tor (10 breaths/minute). Dogs received 10 % O2 and when
necessary room air was introduced to maintain 60 %.
Blood and tissue acquisition
Blood (6 mL) was drawn from the dorso-pedal arterial and
jugular venous and internal carotid catheters at baseline,
30, 60, 90 and 120 min of hypoxia or normoxia. Samples
were transferred into chilled vials, one set containing ethyl-
enediaminetetraacetic acid (EDTA; 1.8 mg K3 EDTA per 1
mL of blood) and the other set containing EDTA, 0.3 M
ethylene glycol tetraacetic acid (EGTA), 0.3 M glutathione.
Plasma was separated by centrifugation (4 °C, 14,000 x g;
























Fig. 1 Lung histology and wet weight to dry weight (LWW/LDW)
ratio. a Interstitial edema and areas of alveolar edema are presented
in CON, CH, and GH on the top and bottom row respectively. b 2 h
of CH and GH increased the LWW/LDW ratio, indicating increased
pulmonary vascular leak. *p < 0.05 compared to CON. Data
presented as mean ± SEM
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hours of hypoxia/normoxia, the animals were euthanized
with sodium pentobarbital (10 mL IV) and the heart and
lungs were removed by median sternotomy. The left caudal
lung lobe was removed, weighed, and oven dried (65 °C for
96 hours until stable weight was achieved) for lung wet
weight to lung dry weight (LWW/LDW) ratios as indices
of pulmonary edema. The right caudal lobe was frozen in
liquid nitrogen and stored at -80 °C for further analysis.
Remaining lung lobes were fixed in 10 % formalin for 24
hours, placed into 70 % ethanol, paraffin embedded and
cut into 4 µm sections for histological analyses. Brainstem,
cerebellum, and left half of the cerebral cortex, were
removed, snap frozen in liquid nitrogen, and stored at -80 °
C for later analysis. A coronal section through the cortex
around the prefrontal lobe was prepared for histological
analyses in a manner identical to that used for lung tissue.
Western blot analyses
Approximately 50 mg of frozen brain cortex and lung
were homogenized (Next Advance Inc, Averill Park, NY,
USA) in 1 mL of ice-cold buffer (40 mM Tris HCl, 10
mM Tris Base, 5 mM MgCl2, 100 mM NaCl, 1 %
TritonX-100, 1 mM EDTA, pH 7.4) with protease and
phosphatase inhibitors (Halt, Thermo Fisher, Rockford,
Table 2 Hemodynamic measurements during experimentation. Data represent mean ± SEM of measures taken every 30 min under
sham operated animals (CON), cerebral hypoxia (CH), and global hypoxia (GH). Baseline values were measured prior to induction of
experimental conditions. The last column in the table represents the mean ± SEM of all time points considering baseline
measurements as covariates
Measures Groups Baseline 30 min 60 min 90 min 120 min Mean ± SEM at all time points
HR CON 116 ± 5 118 ± 14 134 ± 19 122 ± 22 124 ± 9 119 ± 15
(bpm) CH 111 ± 4 116 ± 12 107 ± 5 117 ± 10 124 ± 9 114 ± 10
GH 90 ± 6 111 ± 12 98 ± 11 101 ± 13 103 ± 9 111 ± 15
MAP CON 65 ± 6 78 ± 12 85 ± 1 82 ± 2 83 ± 8 86 ± 4
(mmHg) CH 84 ± 11 82 ± 6 67 ± 6 74 ± 4 73 ± 6 73 ± 2*
GH 81 ± 3 80 ± 2 77 ± 3 79 ± 2 77 ± 2 78 ± 3
PAP CON 15 ± 1 14 ± 3 15 ± 1 14 ± 2 15 ± 1 15 ± 2
(mmHg) CH 22 ± 4 22 ± 2 20 ± 2 23 ± 1 25 ± 1 23 ± 1*
GH 22 ± 2 28 ± 2 24 ± 2 29 ± 3 29 ± 3 27 ± 2*
Pwedge CON 11.7 ± 0.6 12.0 ± 0.6 11.7 ± 0.7 12.3 ± 1.2 12.3 ± 0.9 12.5 ± 0.9
(mmHg) CH 14.2 ± 0.9 13.2 ± 0.8 13.0 ± 0.5 12.3 ± 0.9 12.5 ± 0.9 12.7 ± 0.5
GH 15.8 ± 1.3 15.0 ± 1.2 13.8 ± 1.3 14.8 ± 0.3 15.0 ± 0.4 14.4 ± 0.7
CO CON 2.6 ± 0.3 3.1 ± 0.8 3.3 ± 0.7 3.2 ± 0.9 3.7 ± 0.6 3.8 ± 0.5
(L/min) CH 4.3 ± 1.2 4.3 ± 1.0 4.1 ± 0.7 4.1 ± 0.4 3.8 ± 0.3 3.9 ± 0.3
GH 3.9 ± 0.4 5.4 ± 1.0 5.1 ± 0.4 5.2 ± 0.7 5.1 ± 0.7 5.2 ± 0.4*#
ICP CON 12 ± 3 10 ± 2 11 ± 2 11 ± 3 11 ± 3 14 ± 2
(mmHg) CH 21 ± 3 22 ± 3 21 ± 2 21 ± 3 22 ± 3 17 ± 1
GH 11 ± 2 7 ± 2 10 ± 4 9 ± 3 11 ± 5 13 ± 2
SV CON 23.3 ± 3.4 29.3 ± 11.5 26.8 ± 8.3 28.6 ± 9.5 34.1 ± 9.9 35.4 ± 4.3
(mL) CH 40.8 ± 12.4 39.9 ± 8.7 39.7 ± 7.3 35.9 ± 3.5 31.7 ± 3.1 35.7 ± 2.9
GH 44.8 ± 6.1 48.2 ± 3.9 53.2 ± 4.3 52.7 ± 7.0 50.2 ± 5.7 48.4 ± 3.6*#
PVR CON 1.7 ± 0.9 3.1 ± 0.8 1.5 ± 0.4 2.6 ± 0.7 2.5 ± 0.5 2.4 ± 0.7
(dyn*s/cm^5) CH 2.1 ± 0.5 3.6 ± 1.9 2.1 ± 0.6 2.6 ± 0.4 3.2 ± 0.6 2.8 ± 0.5
GH 1.3 ± 0.2 1.1 ± 0.6 1.8 ± 0.5 1.3 ± 0.9 1.5 ± 0.7 1.6 ± 0.6
SVR CON 24.8 ± 0.9 26.9 ± 4.1 29.6 ± 8.6 29.3 ± 6.5 24.3 ± 7.1 27.6 ± 3.2
(dyn*s/cm^5) CH 27.2 ± 5.2 26.0 ± 7.3 18.3 ± 3.5 19.2 ± 2.7 19.5 ± 2.0 19.8 ± 2.3*
GH 21.9 ± 3.7 16.0 ± 2.6 15.5 ± 1.7 16.4 ± 2.9 15.9 ± 2.8 17.3 ± 2.8*
CPP CON 53 ± 10 68 ± 14 74 ± 3 71 ± 4 72 ± 6 74 ± 3
(mmHg) CH 63 ± 12 60 ± 5 45 ± 6 53 ± 4 51 ± 7 52 ± 2*#
GH 70 ± 5 74 ± 4 68 ± 6 70 ± 3 66 ± 5 67 ± 3
*p < 0.1 compared to CON, #p < 0.05 GH compared to CH
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IL, USA). Samples were centrifuged (4 °C, 10,000 x g, 10
min) and protein concentration of the supernatant was
determined using a bicinchoninic acid assay (Thermo
Fisher, Rockford, IL, USA). Samples were heat denatured
in Laemmli buffer, separated using 10 % SDS-PAGE,
transferred to nitrocellulose paper, and incubated in 5 %
milk in TBST (Tris-buffered saline with tween) for 1
hour prior to immunoblotting. To prepare the nuclear
extracts, 40 mg of cerebral cortex and lung tissue were ho-
mogenized in 200 volumes of Thermo Scientific NE-PER
Nuclear and Cytoplasmic Extraction Kit buffer (Thermo
Fisher, Rockford, IL, USA). 20 µg of the nuclear protein
(lung and brain) was then prepared for immunoblotting as
described above. Antibodies were purchased from Abcam
(Cambridge, MA, USA; HO-1 # Ab13248, NQO1 #
Ab2346) and Santa Cruz Biotechnology (Santa Cruz, CA,
USA; Nrf2 #SC-1302, SOD1# SC-8637). Blots were incu-
bated overnight at 4 °C with primary antibodies diluted
1:200 in TBST, washed in TBST, and incubated with HRP-
conjugated secondary antibody diluted 1:1000 in 5 % milk
in TBST for 1 hour at room temperature (anti-rabbit for
Nrf2, anti-goat for SOD1 and NQO1 and anti-mouse for
HO-1) followed by chemiluminescence detection (West
Dura; Pierce, Rockford, IL, USA). Images were captured
and densitometry conducted using a UVP Bioimaging sys-
tem (Upland, CA, USA). Equal loading was verified using
ponceau staining as well as actin antibodies (SC-8432;
Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Immunohistochemistry (IHC)
Aforementioned 4 μm thick paraffin sections from brain
cortex were mounted on poly-l-lysine slides. Slides were
dewaxed and sections rehydrated by immersion in etha-
nol (100 %, 95 %, and 70 %) and then distilled water.
After washing, sections were preincubated in PBS sup-
plemented with 0.5 % BSA and 10 % normal horse serum
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1
hour, then incubated overnight with mouse monoclonal
anti-APPA4 antibody diluted 1:100 in PBS containing 0.5
% BSA and 15 % normal horse serum. The sections were
then incubated for 1 hour with 1:1000 biotin-labeled anti-
mouse secondary antibodies (Santa Cruz, CA, USA),

































































































Fig. 2 Percent changes in catecholamine concentrations in venous blood extracted from the jugular vein after 60 min of treatment. a Percent
change of norepinephrine concentrations from baseline to time 60 in CON, CH and GH groups. b Percent change of epinephrine concentrations




































Fig. 3 HO-1, phase II antioxidant protein, expression in brain tissue,
measured by western blotting. Bar graphs (top) reflect the protein
content normalized to actin and expressed as % CON while bottom
images are representative immunoblots and actin as a loading
control protein. *p < 0.05 compared to CON. #p < 0.05 compared to
CH. Data presented as mean ± SEM
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solution containing 3′, 3′-diaminobenzidine (DAB) tetra-
hydrochloride dihydrate (Dakocytomation, CA, USA) and
hydrogen peroxide. Finally, the sections were counter-
stained with hematoxylin. Signal density was quantified
using Image J software (NIH, USA).
Assessment of oxidative stress
Carbonylated proteins of lung and brain tissues were de-
tected and analyzed following derivatization of protein
carbonyl groups with 2, 4-dinitrophenylhydrazine, using
the OxyBlot kit (Millipore, Billerica, MA, USA). Immu-
nodetection was performed using 15 μg of protein per
lane (3µg/µl) and primary antibody directed against dini-
trophenylhydrazone (Millipore, Billerica, MA, USA). To
measure malondialdehyde (MDA) concentrations, 25 mg
of lung and brain tissue was quantitated using a TBAR
assay kit (Cayman Chemical, Ann Arbor, MI, USA) per
manufacturer recommendations. Plasma catecholamines:
Plasma obtained from the blood that was collected into
tubes with EGTA/glutathione was used to quantitate cir-
culating norepinephrine and epinephrine with enzyme-
linked immunosorbent assay (ELISA) (Rocky Mountain
Diagnostics Inc., CO, USA).
Statistical analyses
Hemodynamic data from all 13 subjects were included
in analyses (CH=6, GH=4, CON=3). Unless otherwise
noted, the remaining analyses were conducted using data
from 12 dogs (tissues were not collected from the first
CH procedure). Statistical analyses were performed with
the SAS (version 9) statistical package (SAS, Cary, NC)
and SPSS (IBM, version 19). Inter-subject variability in
baseline hemodynamic measurements was controlled for
by considering baseline measurements as covariates.
Data were analyzed by one-way repeated measures of
analysis of variance (ANOVA). Western blot, IHC, and
catecholamine data were analyzed by one-way ANOVA.
Significance was established a priori at p < 0.1 due to
the necessary small sample size using this large animal
model.
Results
Oxygen saturation: To maintain the desired hypoxemic
exposure to either cerebral or global hypoxia, or ensure
a normal arterial oxygen saturation (SaO2), SaO2 was
continuously monitored and recorded at 15 min inter-
vals in all dogs. For dogs assigned to the cerebral hyp-
oxia (CH) group, measurement of femoral and carotid
SaO2 verified that cerebral hypoxia was established in
the presence of systemic normoxia (SaO2 54 ± 6 %
carotid vs.94 ± 1.7 % femoral arterial blood; Table 1,
p < 0.05). Global hypoxia (GH) elicited the expected
lower SaO2 in both femoral and carotid arteries dur-
ing the 2-h study period. Thus, we successfully
induced and maintained both isolated cerebral hyp-
oxia as well as global hypoxia.
Pulmonary edema: Assessment of the lung at nec-
ropsy, lung wet weight to dry weight (LWW/LDW) ra-
tios, and histological analyses were used to evaluate the
presence of pulmonary edema. Compared to controls
(CON), the gross specimens of lungs showed more vis-
ible areas of petechiae and marked areas of interstitial
and alveolar edema in the CH and GH cohorts (Fig. 1a)
as well as greater LWW/LDW ratios (Fig. 1b, p < 0.05).
These findings confirm that both isolated cerebral hyp-
oxia and global hypoxia elicited the formation of pul-
monary edema during the 2-h study period.
Hemodynamics: Hemodynamic measurements are pre-
sented in Table 2. Mean cardiac output (CO) at all time-
points was higher in the GH (p = 0.07) compared to CH
(p < 0.05) and CON (p = 0.07) cohorts. The higher CO in
GH animals was attributed to a higher SV (p < 0.05) of
GH animals. Our data show MAP was lower in CH
compared to CON groups (p < 0.05), but no difference
was noted between the CH and GH cohorts. Compared
to CON cohorts, the systemic vascular resistance (SVR)
was lower in GH and CH cohorts compared to CON
(p < 0.1). Compared to the CON, pulmonary arterial
pressure (PAP) at 2 h was greater in the GH and CH
cohort (p < 0.1). Finally, Pwedge pressure was similar
across groups.
Intracranial pressure: Mean intracranial pressure (ICP)
recordings did not show any significant changes during
the 2 h time period within or between groups. Calcula-
tion of cerebral perfusion pressure (CPP) revealed a
lower CPP in the CH cohort compared to CON and GH
(Table 2, p < 0.05).
Catecholamines: To assess SNS activity, plasma cat-
echolamine concentrations were measured at baseline
and after 60 min of the study. Similar to previous work
in which Irwin et al. reported a cerebral hypoxia induced
increase in norepinephrine [10], there was a greater nor-
epinephrine (p = 0.07) and epinephrine (p = 0.10) in CH
compared to CON (Fig. 2a-b). Norepinephrine and epi-
nephrine concentrations increased between baseline
(time 0) to 60 min in nearly all individual CH and GH
canines, while catecholamines remained unchanged in
the CON dogs (individual data not shown).
Hypoxia induced oxidative stress: Presence of oxida-
tive stress in lung and brain tissues was evaluated by
assessing lipid peroxidation and protein carbonylation.
No group differences in these markers of oxidative stress
were detectable at the 2-h time point of treatment (data
not shown). To assess Nrf2 activation, the nuclear to
cytoplasmic ratio of this protein in lung and brain was
measured in all three groups. No group differences in
the nuclear to cytoplasmic ratio of Nrf2 were detectable
at the 2-h time point of treatment (data not shown). To
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detect whether there was a hypoxia-induced upregula-
tion of ARE-regulated phase II antioxidants, expression
of Nrf2, HO-1, NQO1, and SOD1 were measured in
lung and brain of all three animal groups. There was no
difference in Nrf2 expression in lung or brain, or in lung
HO-1 or brain SOD1, across treatment groups (data
not shown). Brain HO-1 expression was greater in
CH compared to CON and in CH compared to GH
(Fig. 3, p < 0.05).
Discussion
Cerebral hypoxia is a common feature of many neuro-
pathologies [23], yet limited data are available on the
mechanisms that induce pulmonary edema in the pres-
ence of hypoxic brain insults. The current study repre-
sents an appreciable advancement of previous methods
[9, 10] due to consideration of ICP and controlling for
CBF. In the presence of similar CBF, both cerebral and
global hypoxia resulted in pulmonary edema. Currently
there is no clear evidence of how changes in
hemodynamic parameters are involved in the onset of
NPE. Hence observing the role of hypoxia, irrespective
of changes in blood flow during the generation of
edema in lung, was an important additional insight to
the previous investigation. The present study suggests
that at 2 h of cerebral or global hypoxia there was no
detectable oxidative stress, however, our data do sug-
gest involvement of sympathetic activity in induction of
pulmonary edema.
Novelty of the model: Several important and novel as-
pects of the model are noteworthy. This experiment was
the first to monitor ICP in the canine model during
cerebral hypoxia, allowing for the calculation of CPP.
Even though ICP was measured indirectly by probe
placement in the subdural space rather than in the ven-
tricles, it allowed us to assess the magnitude of change
in ICP. This study was also the first to control CBF dur-
ing an isolated cerebral hypoxia model by matching CBF
during both cerebral and global hypoxia. We found that
CBF does not appear to be a major determinant of de-
velopment of pulmonary edema. That is, pulmonary
edema may occur in the absence of changes in CBF, an
observation not addressed in our previous study.
Pulmonary hemodynamics: It has been suggested that
an increase in PAP contributes to the pathogenesis of
NPE [27]. We found that PAP was significantly greater
in CH and GH compared to CON. The absence of a
greater afterload in pulmonary vasculature in our study
was indicated by a lack of differences in Pwedge between
the CH and GH compared to CON. Thus we have ob-
served that an increase in PAP can occur in NPE.
Systemic hemodynamics: Sensing of hypoxia occurs
through specialized chemoreceptor cells located in bifur-
cation of carotid artery that regulate cardiovascular and
ventilatory rates. Hypoxia, in general, decreases the vas-
cular resistance and CO is subsequently altered so that
physiologic MAP is maintained [28]. As shown in the
current study, GH led to greater CO compared to CH.
Augmented CO in GH group was attributed to an in-
crease in SV since the HR in the GH animals was not
different compared to CON and CH. MAP in GH and
CON was not significantly different, which implies a CO
compensation for hypoxic vasodilation. In our study, the
hypoxic perfusate to the brain bypassed the chemorecep-
tors such that hypoxia was not detected by the chemore-
ceptors and MAP was significantly attenuated in CH
compared to CON. Taken together, systemic compensa-
tory responses to hypoxia were absent in our isolated
cerebral hypoxia model.
The dissociation between circulating catecholamines
and MAP in CH was unexpected, but is not without pre-
cedent. For example, in humans, while breathing hyp-
oxic gas mixtures, sympathetic activation in the absence
of vasoconstriction has been documented [29]. Further,
in older men with hypertension, 24-h circulating nor-
epinephrine concentration is inversely associated with
mean arterial pressure [30]. Finally, during surgery fol-
lowing administration of the anesthetic desfluranes,
hemodynamic responses to catecholamines are reversed
[31]. Potential mechanisms for reduced and dissociated
catecholamine responses include decreased adrenergic
receptor sensitivity, increased catecholamine clearance
[29], altered catecholamine metabolism, and/or acute
septic [32, 33] or hemorrhagic shock [34]. The specific
mechanism contributing to increased norepinephrine in
the absence of an increase in mean arterial pressure in
our study is unclear but warrants further investigation.
SNS activity: Acute hypoxia has been well-established
as a sympathetic activator [28]. However, the role of
SNS activity in development of NPE in isolated cerebral
hypoxia compared to global hypoxia is not known. To
evaluate the systemic SNS activity, plasma catechol-
amine concentrations were quantified. Since catechol-
amine concentrations are the net result of secretion,
spill-over, reuptake, and excretion, comparison of con-
centrations at baseline and 60 min was performed to
better characterize the net change in each canine. In-
creases in catecholamines, CO, and SV in GH suggest
that the physiological chemoreceptor response may be
activated through the SNS in this group.
A 6-fold increase in norepinephrine in CH compared
to CON suggests that SNS activity may be higher with
cerebral hypoxia compared to normoxia. An increase in
SNS activity in CH occurred in the presence of increased
PAP. Since the hypoxic blood bypassed the carotid che-
moreceptors in the CH group such that chemoreceptor
“sensing” of hypoxia could not occur, SNS activation in
the CH group likely did not ensue through this pathway.
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Neurons that normally contribute to oxygen sensing are
located in the rostral ventrolateral medulla, the caudal
hypothalamus, the pre-Bötzinger complex, and the
nucleus tractus solitarius. In the absence of a carotid
chemoreceptor response, our findings suggest oxygen
sensing in these higher centers are involved in SNS acti-
vation and the subsequent increase in PAP that contrib-
ute to the formation of pulmonary edema. Whether or
not other factors are involved in SNS activation will re-
quire further investigation.
Role of oxidative stress in NPE: Whether or not oxida-
tive stress contributes to sympathetic activation, in-
creased PAP, or pulmonary edema is unclear. In our
study, markers of oxidative stress and antioxidant re-
sponse were not higher in lung tissue at 2 h of hypoxia.
However brain HO-1, a phase II antioxidant down-
stream of Nrf2, was significantly higher in CH compared
to CON. In vitro data from our lab have shown that
Nrf2 translocates to the nucleus, an indicator of Nrf2 ac-
tivation, within 15 min of an oxidative challenge [22].
However, Nrf2 nuclear localization is not sustained as
there is a subsequent nuclear export of Nrf2 [35]. There-
fore, we were not surprised by the absence of Nrf2 ex-
pression in the nucleus after 2 h of hypoxia, yet higher
levels of brain HO-1, a Nrf2 downstream protein, in CH
compared to CON suggest Nrf2 was activated earlier in
the experiment.
Higher levels of brain HO-1 in isolated cerebral hyp-
oxia in the current study suggest that redox sensitive
signaling in the brain could contribute to activation of
the SNS and induction of pulmonary edema, a finding
supported by previous reports [24, 36, 37]. For example,
hypoxia acts directly on brainstem neurons, as opposed
to only carotid body inputs that are carried within the
carotid sinus nerve to the nucleus tractus solitarius and
the brainstem respiratory centers [37]. Knowing that
hypoxia can induce ROS production [14, 15], it is pos-
sible that brain hypoxia activates higher centers of SNS
through redox sensitive signaling pathways, which leads
to increased PAP and induction of pulmonary edema.
Also, in the presence of elevated hypothalamic NADPH
oxidase activity (a marker of oxidative stress), the ex-
pression level of tyrosine hydroxylase, an enzyme re-
sponsible for the synthesis of catecholamines, was
higher in the nucleus tractus solitarius of the brain
stem [38]. These data, along with previous findings
that HO-1 is induced in hypoxia-sensitive brain re-
gions [24, 39], are consistent with our data suggesting
that increased expression of HO-1, a compensatory
response to oxidative stress, could act as a sensor in
brain hypoxia and may have a role in induction of
SNS activity.
Limitations of the study: We recognize that all of our
hemodynamic measurements were performed in
anesthetized animals. We have noted that two out of six
animals in CH group had high values of ICP at the base-
line. Further PAP baseline values were higher than ex-
pected in two animals in CH and GH groups. This could
be attributed to the variable response to anesthetics [40].
However, none of the procedures described could have
been performed in the absence of anesthesia and thus, we
feel this is an acceptable limitation. Several of the differ-
ences we report did not attain statistical significance
although they may be physiologically significant [41].
Finally, on a technical note, ICP was not determined
directly, rather it was estimated from subdural probe place-
ment. This approach is not without precedent, indeed, it
has been validated against gold-standard techniques [42].
Conclusions
In conclusion, the present study suggests that increased
SNS activity and PAP, in the absence of CBF alterations,
contributes to pulmonary edema in isolated cerebral
hypoxia. Furthermore, isolated cerebral hypoxia for 2 h
induces HO-1 in the brain, suggesting redox sensitive
signaling and a compensatory antioxidant response to
hypoxia. In this way, it seems that HO-1 may be an oxy-
gen sensor in the brain, leading to compensatory activa-
tion of the SNS, and induction of pulmonary edema
through a rise in PAP.
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